Indication

Congenital sucrase-isomaltase deficiency

Congenital sucrase-isomaltase deficiency is a rare inherited gastrointestinal disorder caused by pathogenic variants in the SI gene that lead to deficient or absent activity of the sucrase-isomaltase enzyme complex on the enterocyte brush border. Read more about Congenital sucrase-isomaltase deficiency

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Congenital sucrase-isomaltase deficiency therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Congenital sucrase-isomaltase deficiency preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Congenital sucrase-isomaltase deficiency.

Congenital sucrase-isomaltase deficiency is a rare inherited gastrointestinal disorder caused by pathogenic variants in the SI gene that lead to deficient or absent activity of the sucrase-isomaltase enzyme complex on the enterocyte brush border.

Without this dual enzyme, the small intestine cannot properly hydrolyze dietary disaccharides and starch fragments, notably sucrose and isomaltose-derived dextrins, into absorbable monosaccharides.

The unabsorbed carbohydrates pass into the colon, drawing water and undergoing bacterial fermentation.

This process typically manifests in infancy during the weaning transition to dietary sugars and starches with chronic osmotic diarrhea, abdominal distension, cramping, gas, and subsequent failure to thrive or malnutrition.

Personalize your experience

Follow Congenital sucrase-isomaltase deficiency and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it